MHC class I-presented T cell epitopes identified by immunoproteomics analysis are targets for a cross reactive influenza-specific T cell response.
Influenza virus infection and the resulting complications are a significant global public health problem. Improving humoral immunity to influenza is the target of current conventional influenza vaccines, however, these are generally not cross-protective. On the contrary, cell-mediated immunity gener...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8106d4993fcc43cfa92772bf3e17a563 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:8106d4993fcc43cfa92772bf3e17a563 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:8106d4993fcc43cfa92772bf3e17a5632021-11-18T08:09:46ZMHC class I-presented T cell epitopes identified by immunoproteomics analysis are targets for a cross reactive influenza-specific T cell response.1932-620310.1371/journal.pone.0048484https://doaj.org/article/8106d4993fcc43cfa92772bf3e17a5632012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23144892/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203Influenza virus infection and the resulting complications are a significant global public health problem. Improving humoral immunity to influenza is the target of current conventional influenza vaccines, however, these are generally not cross-protective. On the contrary, cell-mediated immunity generated by primary influenza infection provides substantial protection against serologically distinct viruses due to recognition of cross-reactive T cell epitopes, often from internal viral proteins conserved between viral subtypes. Efforts are underway to develop a universal flu vaccine that would stimulate both the humoral and cellular immune responses leading to long-lived memory. Such a universal vaccine should target conserved influenza virus antibody and T cell epitopes that do not vary from strain to strain. In the last decade, immunoproteomics, or the direct identification of HLA class I presented epitopes, has emerged as an alternative to the motif prediction method for the identification of T cell epitopes. In this study, we used this method to uncover several cross-specific MHC class I specific T cell epitopes naturally presented by influenza A-infected cells. These conserved T cell epitopes, when combined with a cross-reactive antibody epitope from the ectodomain of influenza M2, generate cross-strain specific cell mediated and humoral immunity. Overall, we have demonstrated that conserved epitope-specific CTLs could recognize multiple influenza strain infected target cells and, when combined with a universal antibody epitope, could generate virus specific humoral and T cell responses, a step toward a universal vaccine concept. These epitopes also have potential as new tools to characterize T cell immunity in influenza infection, and may serve as part of a universal vaccine candidate complementary to current vaccines.James S TestaVivekananda ShettyJulie HafnerZacharie NickensShivali KamalGomathinayagam SinnathambyRamila PhilipPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 11, p e48484 (2012) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q James S Testa Vivekananda Shetty Julie Hafner Zacharie Nickens Shivali Kamal Gomathinayagam Sinnathamby Ramila Philip MHC class I-presented T cell epitopes identified by immunoproteomics analysis are targets for a cross reactive influenza-specific T cell response. |
description |
Influenza virus infection and the resulting complications are a significant global public health problem. Improving humoral immunity to influenza is the target of current conventional influenza vaccines, however, these are generally not cross-protective. On the contrary, cell-mediated immunity generated by primary influenza infection provides substantial protection against serologically distinct viruses due to recognition of cross-reactive T cell epitopes, often from internal viral proteins conserved between viral subtypes. Efforts are underway to develop a universal flu vaccine that would stimulate both the humoral and cellular immune responses leading to long-lived memory. Such a universal vaccine should target conserved influenza virus antibody and T cell epitopes that do not vary from strain to strain. In the last decade, immunoproteomics, or the direct identification of HLA class I presented epitopes, has emerged as an alternative to the motif prediction method for the identification of T cell epitopes. In this study, we used this method to uncover several cross-specific MHC class I specific T cell epitopes naturally presented by influenza A-infected cells. These conserved T cell epitopes, when combined with a cross-reactive antibody epitope from the ectodomain of influenza M2, generate cross-strain specific cell mediated and humoral immunity. Overall, we have demonstrated that conserved epitope-specific CTLs could recognize multiple influenza strain infected target cells and, when combined with a universal antibody epitope, could generate virus specific humoral and T cell responses, a step toward a universal vaccine concept. These epitopes also have potential as new tools to characterize T cell immunity in influenza infection, and may serve as part of a universal vaccine candidate complementary to current vaccines. |
format |
article |
author |
James S Testa Vivekananda Shetty Julie Hafner Zacharie Nickens Shivali Kamal Gomathinayagam Sinnathamby Ramila Philip |
author_facet |
James S Testa Vivekananda Shetty Julie Hafner Zacharie Nickens Shivali Kamal Gomathinayagam Sinnathamby Ramila Philip |
author_sort |
James S Testa |
title |
MHC class I-presented T cell epitopes identified by immunoproteomics analysis are targets for a cross reactive influenza-specific T cell response. |
title_short |
MHC class I-presented T cell epitopes identified by immunoproteomics analysis are targets for a cross reactive influenza-specific T cell response. |
title_full |
MHC class I-presented T cell epitopes identified by immunoproteomics analysis are targets for a cross reactive influenza-specific T cell response. |
title_fullStr |
MHC class I-presented T cell epitopes identified by immunoproteomics analysis are targets for a cross reactive influenza-specific T cell response. |
title_full_unstemmed |
MHC class I-presented T cell epitopes identified by immunoproteomics analysis are targets for a cross reactive influenza-specific T cell response. |
title_sort |
mhc class i-presented t cell epitopes identified by immunoproteomics analysis are targets for a cross reactive influenza-specific t cell response. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2012 |
url |
https://doaj.org/article/8106d4993fcc43cfa92772bf3e17a563 |
work_keys_str_mv |
AT jamesstesta mhcclassipresentedtcellepitopesidentifiedbyimmunoproteomicsanalysisaretargetsforacrossreactiveinfluenzaspecifictcellresponse AT vivekanandashetty mhcclassipresentedtcellepitopesidentifiedbyimmunoproteomicsanalysisaretargetsforacrossreactiveinfluenzaspecifictcellresponse AT juliehafner mhcclassipresentedtcellepitopesidentifiedbyimmunoproteomicsanalysisaretargetsforacrossreactiveinfluenzaspecifictcellresponse AT zacharienickens mhcclassipresentedtcellepitopesidentifiedbyimmunoproteomicsanalysisaretargetsforacrossreactiveinfluenzaspecifictcellresponse AT shivalikamal mhcclassipresentedtcellepitopesidentifiedbyimmunoproteomicsanalysisaretargetsforacrossreactiveinfluenzaspecifictcellresponse AT gomathinayagamsinnathamby mhcclassipresentedtcellepitopesidentifiedbyimmunoproteomicsanalysisaretargetsforacrossreactiveinfluenzaspecifictcellresponse AT ramilaphilip mhcclassipresentedtcellepitopesidentifiedbyimmunoproteomicsanalysisaretargetsforacrossreactiveinfluenzaspecifictcellresponse |
_version_ |
1718422118288326656 |